Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Insmed (INSM) Misses Q1 EPS by 1c, Revenues Miss
May 6, 2021 8:19 AM EDTInsmed (NASDAQ: INSM) reported Q1 EPS of ($0.89), $0.01 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $40.21 million versus the consensus estimate of $41.64 million.
"Insmed is off to a strong start in 2021, with important advancements across each of our three... More
